HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Coagulation-fibrinolytic and kinin-forming systems in toxemia of pregnancy.

Abstract
The relationship between the hemostatic system and the severity of toxemia was studied in 78 pregnant women with toxemia. The activities of plasma antithrombin III (AT-III), prekallikrein, plasminogen, alpha 2-plasmin inhibitor and factor XIII were determined using the chromogenic substrate and fluorescent methods. The antigens of both AT-III and factor XIII were determined by the single radial immunodiffusion method. Plasma bradykinin was determined by radioimmunoassay. The main results obtained were as follows. Both activities of AT-III and plasma prekallikrein decreased as the gestosis index increased (p less than 0.001), and a significant negative correlation was observed between the total score of the gestosis index and AT-III (r = -0.447, p less than 0.005) or plasma prekallikrein (r = -0.434, p less than 0.005). The levels of plasminogen, alpha 2-plasmin inhibitor and factor XIII decreased and plasma bradykinin increased in toxemia. Among the various factors, plasma AT-III and prekallikrein were the most sensitive indicators of the severity of toxemia.
AuthorsM Hayakawa, M Maki
JournalGynecologic and obstetric investigation (Gynecol Obstet Invest) Vol. 26 Issue 3 Pg. 181-90 ( 1988) ISSN: 0378-7346 [Print] Switzerland
PMID3240888 (Publication Type: Journal Article)
Chemical References
  • Antigens
  • alpha-2-Antiplasmin
  • Antithrombin III
  • Plasminogen
  • Factor XIII
  • Prekallikrein
  • Bradykinin
Topics
  • Antigens (analysis)
  • Antithrombin III (analysis, immunology)
  • Blood Coagulation
  • Bradykinin (blood)
  • Disseminated Intravascular Coagulation (blood)
  • Factor XIII (analysis, immunology)
  • Female
  • Fibrinolysis
  • Humans
  • Plasminogen (analysis)
  • Pre-Eclampsia (blood)
  • Pregnancy
  • Prekallikrein (analysis)
  • alpha-2-Antiplasmin (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: